Addition of pramlintide to insulin therapy improves metabolic control in type 1 and 2 diabetics June 21, 2000
Symbollon completes phase I trial with IoGen for treatment of fibrocystic breast disease June 21, 2000
Itavastatin favorably affects lipid profile without influencing glucose metabolism in NIDDM June 20, 2000
RSS